Az antithromboticus kezelés újdonságai a kardiológiában

Translated title of the contribution: What is new in antithrombotic therapy in cardiology

Research output: Contribution to journalArticle

Abstract

Substantial development has been made in the field of antithrombotic therapy of heart diseases during the last two years. The "gold constant" combination of heparin, coumadin, aspirin and clopidogrel has been started to be questioned. All of the traditional drugs have or will have new classmates in the near future. New drugs have become available with new targets, new way of action with theoretical as well as practical advantages.

Translated title of the contributionWhat is new in antithrombotic therapy in cardiology
Original languageHungarian
Pages (from-to)2016-2020
Number of pages5
JournalOrvosi hetilap
Volume153
Issue number51
DOIs
Publication statusPublished - Dec 1 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'What is new in antithrombotic therapy in cardiology'. Together they form a unique fingerprint.

  • Cite this